A Multicenter, Open-Label, Ascending Multiple-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age With Selected Serious Infections.

Trial Profile

A Multicenter, Open-Label, Ascending Multiple-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age With Selected Serious Infections.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Nov 2014

At a glance

  • Drugs Tigecycline (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 23 Oct 2012 Primary endpoints amended as reported by ClinicalTrials.gov.
    • 15 Mar 2012 Additional trial location (Mexico, Taiwan) identified as reported by EudraCT.
    • 14 Apr 2011 Last checked against United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top